23andMe Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:23andMe Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10313
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. Its service portfolio includes clinical development, research and development, ancestry services, commercialization services, and information of personal ancestry, genealogy and inherited traits. 23andMe’s ancestry services comprise ancestry composition, family tree tool, DNA relatives, maternal and paternal lineages, and neanderthal percentage. The company helps individuals to understand their genetic information using DNA analysis technologies and web-based interactive tools. It serves students, clinicians, and developers. 23andMe is headquartered in Mountain View, California, the US.

23andMe Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
23andMe Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
23andMe Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
23andMe Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
23andMe Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
23andMe Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
23andMe Inc, Medical Equipment, Deal Details 10
Venture Financing 10
23andMe to Raise up to USD300 Million in Financing 10
23andMe Raises USD250 Million in Venture Financing 11
Freenome Raises Additional USD7 Million in Series A Financing 13
Partnerships 14
Lieber Institute for Brain Development (LIBD) Partners with 23andME 14
Acquisition 15
23andMe Acquires CureTogether 15
23andMe Inc – Key Competitors 16
23andMe Inc – Key Employees 17
23andMe Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Legal and Regulatory 19
Oct 31, 2018: 23andMe granted the first and only FDA Authorization for direct-to-consumer pharmacogenetic reports 19
Government and Public Interest 20
Jun 17, 2018: Breast cancer researcher warns against online genetic tests 20
Feb 20, 2018: At-Home Genetic Testing Leads to Misinterpretations of Results 22
Feb 22, 2017: Celmatix and 23andMe Announce Launch of Fertility Research Community 23
Product News 24
Apr 06, 2017: FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions 24
Other Significant Developments 26
Aug 28, 2018: 23andme turns off consumer access to porting their genetic data to Timidna, disappointing many consumers 26
Aug 21, 2018: Dash Genomics launches a personalized Alzheimer’s Disease analysis using genetic data 27
May 03, 2017: 23andMe and German Pain Specialist Grunenthal Explore the Genetics of Pain to Help Identify New Treatments for Patients 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
23andMe Inc, Medical Equipment, Key Facts 2
23andMe Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
23andMe Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
23andMe Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
23andMe Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
23andMe Inc, Deals By Market, 2012 to YTD 2018 8
23andMe Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
23andMe to Raise up to USD300 Million in Financing 10
23andMe Raises USD250 Million in Venture Financing 11
Freenome Raises Additional USD7 Million in Series A Financing 13
Lieber Institute for Brain Development (LIBD) Partners with 23andME 14
23andMe Acquires CureTogether 15
23andMe Inc, Key Competitors 16
23andMe Inc, Key Employees 17

List of Figures
23andMe Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
23andMe Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
23andMe Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
23andMe Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
23andMe Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
23andMe Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
23andMe Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
23andMe Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[23andMe Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fresenius Kabi AG:企業の戦略的SWOT分析
    Fresenius Kabi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • WAVE Life Sciences Ltd (WVE):製薬・医療:M&Aディール及び事業提携情報
    Summary WAVE Life Sciences Ltd (WAVE Life Sciences), formerly WAVE Life Sciences Pte Ltd is a genetic medicine company that develops stereopure nucleic acid therapies. The company's pipeline products comprise multiple oligonucleotide modalities such as exon-skipping and single-stranded RNAi, and ant …
  • SuperSonic Imagine SA (SSI):医療機器:M&Aディール及び事業提携情報
    Summary SuperSonic Imagine SA (SuperSonic) is a medical device company that develops and supplies ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company offers ultrasound system, aixplorer that finds clinical applications in breast, abdomen, liver, vascular, …
  • Sanford Health-製薬・医療分野:企業M&A・提携分析
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center’s medical services include allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox …
  • Helmerich & Payne Inc (HP):企業の財務・戦略的SWOT分析
    Helmerich & Payne Inc (HP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Northeastern Rural Electric Membership Corp:企業の戦略的SWOT分析
    Northeastern Rural Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Genera Biosystems Ltd (GBI)-医療機器分野:企業M&A・提携分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • Clovis Oncology Inc (CLVS)-医療機器分野:企業M&A・提携分析
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …
  • Intermediate Capital Group Plc:企業の戦略・SWOT・財務情報
    Intermediate Capital Group Plc - Strategy, SWOT and Corporate Finance Report Summary Intermediate Capital Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • UnitedHealth Group Inc (UNH):製薬・医療:M&Aディール及び事業提携情報
    Summary UnitedHealth Group Inc (UnitedHealth Group) is a diversified health care company. It offers health care services and products through two distinct platforms, namely UnitedHealthcare and Optum. Its UnitedHealthcare platform provides health care coverage and benefit services; and Optum platfor …
  • HDFC Standard Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    HDFC Standard Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary HDFC Standard Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Hebron Technology Co., Ltd. (HEBT):企業の財務・戦略的SWOT分析
    Hebron Technology Co., Ltd. (HEBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Walvax Biotechnology Co Ltd (300142):製薬・医療:M&Aディール及び事業提携情報
    Summary Walvax Biotechnology Co Ltd (Walvax) is a biopharmaceutical company that develops, produces and markets bio-medical products including vaccines and blood products. The company's products include haemophilus influenzae vaccine for the prevention of infectious diseases such as meningitis. Walv …
  • TAT Technologies, Ltd.:企業の戦略・SWOT・財務情報
    TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ConAgra Foods Inc:戦略・SWOT・企業財務分析
    ConAgra Foods Inc - Strategy, SWOT and Corporate Finance Report Summary ConAgra Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sygnature Discovery Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sygnature Discovery Ltd (Sygnature) is a drug discovery company that offers medicinal chemistry, bioscience, computational chemistry, and fragment-based drug discovery programs. The company offers services for various phases of drug discovery which include hit identification, hit to lead, an …
  • Fidelity Bank Plc:企業の戦略・SWOT・財務情報
    Fidelity Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Fidelity Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fluor Corporation (FLR)-エネルギー分野:企業M&A・提携分析
    Summary Fluor Corporation (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other ser …
  • Fossil Group, Inc. (FOSL):企業の財務・戦略的SWOT分析
    Fossil Group, Inc. (FOSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Territorial Generating Company #2 (TGKB)-エネルギー分野:企業M&A・提携分析
    Summary Territorial Generating Company #2 (TGC-2) is a power generating company. The company produces and transmits electricity, as well as heat, such as steam and hot water. TGC-2 through its subsidiaries offers its products and services to customers located in Arkhangelsk, Vologda, Kostroma, Novgo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆